Estrogen secreting adrenal adenocarcinoma in an 18-month-old boy: aromatase activity, protein expression, mRNA and utilization of gonadal type promoter

• Published in: Endocrine journal 2000-12, Vol.47 (6), p.723-730
• Main Authors: Watanabe, T, Yasuda, T, Noda, H, Wada, K, Kazukawa, I, Someya, T, Minamitani, K, Minagawa, M, Wataki, K, Matsunaga, T, Ohnuma, N, Kohno, Y, Harada, N
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - complications; Adenocarcinoma - enzymology; Adenocarcinoma - surgery; Adrenal Gland Neoplasms - complications; Adrenal Gland Neoplasms - enzymology; Adrenal Gland Neoplasms - surgery; Adrenocorticotropic Hormone - blood; Aromatase - analysis; Aromatase - genetics; Aromatase - metabolism; Blotting, Western; Dehydroepiandrosterone Sulfate - blood; Estradiol - blood; Estrogens - metabolism; Exons; Follicle Stimulating Hormone - blood; Gonadotropin-Releasing Hormone; Gynecomastia - etiology; Humans; Hydrocortisone - blood; Infant; Insulin; Luteinizing Hormone - blood; Male; Promoter Regions, Genetic; Renin - blood; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - analysis; Testis - enzymology; Testosterone - blood
• ISSN: 0918-8959
• DOI: 10.1507/endocrj.47.723

We examined clinical, endocrinological and molecular biological aspects of an estrogen-secreting adrenal carcinoma in an 18-month-old male to clarify the pathogenesis of this condition. An 18-month-old boy was referred for evaluation of progressive bilateral gynecomastia and appearance of pubic hair. The patient had elevated plasma estradiol (349 pg/ml) and testosterone (260 ng/dl) levels that completely suppressed FSH and LH levels, and was subsequently diagnosed with an adrenal tumor on the right side. After removal of a 300-g adenocarcinoma, gynecomastia regressed and essentially normal hormone levels were restored. Aromatase activity in the tumor tissue determined by the 3H-water method was 71.0-104.4 pmol/min/mg protein. High levels of aromatase protein and mRNA in the tumor tissue were also demonstrated, while neither aromatase activity nor protein was detected in normal adrenal glands. To investigate the regulation of aromatase expression in the adrenal carcinoma, we examined the usage of alternate promoters responsible for aromatase gene transcription. In the present case, the amounts of aromatase mRNA utilizing gonadal types of exon 1c (1.3) and 1d (II) were significantly higher than those that using other exon 1s. This result suggested that the utilization of a gonadal-type exon 1 might be involved in the over-production of aromatase in estrogen-secreting adrenal carcinoma.